| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.098 | 0.09 |